Salivary Gland Cancer

Our head and neck specialists are experienced in using highly technical procedures to remove salivary gland cancer while preserving or reconstructing important nerves. A team of experts, including ear, nose, and throat specialists called otolaryngologists, surgeons, radiation oncologists, and medical oncologists, works together to provide evidence-based, compassionate care. Rehabilitation experts manage any treatment-related side effects, and integrative medicine specialists offer services to support your overall wellbeing.

Clinical Trials and Research Studies

Phase 1/2

A Phase 1/2 Study Exploring the Safety Tolerability and Efficacy of INCAGN01949 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Learn More

Phase 1

A PHASE I AND EXPANSION COHORT STUDY OF ADJUVANT CISPLATIN INTENSITY-MODULATED RADIOTHERAPY AND MK-3475 (PEMBROLIZUMAB) IN HIGH-RISK HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC)

Learn More

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More

Phase 1

A Phase 1 Open-Label Dose-Escalation and Cohort Expansion First-in-Human Study of the Safety Tolerability Activity and Pharmacokinetics of REGN3767 (anti-LAG-3 mAb) Administered Alone or in Combination with REGN2810 (anti-PD-1 mAb) in Patients with Ad

Learn More